← All Stories
Regulatory

Ren Life Sciences Partners II L.P. Files SEC Exemption Notice

Ren Life Sciences Partners II L.P. submitted a filing to the SEC claiming exemptions under Sections 3(c)(1) and 3(c)(7) of the Investment Company Act.

Close-up of a hand signing documents with a pen, symbolizing an important business contract.
Photo by Kampus Production on Pexels

Ren Life Sciences Partners II L.P. Files SEC Exemption Notice

Ren Life Sciences Partners II L.P. filed a notice with the U.S. Securities and Exchange Commission on September 3, 2026. The filing carries accession number 0000950142-26-002488 and totals 9 KB in size.

Filing Details

The document was submitted under Item 3C of the applicable form, referencing Investment Company Act Section 3(c). It specifically identifies Section 3(c)(1) and Section 3(c)(7) as the bases for the claimed exemptions.

according to SEC EDGAR.

Entity Information

The filer is identified as Ren Life Sciences Partners II L.P. with CIK 0002152994. The filing marks the entity’s notice regarding private fund status under the Investment Company Act.

Context on Exemption Filings

Such filings are standard for private funds seeking to avoid registration as investment companies under the Investment Company Act. The cited sections address funds with limited numbers of investors and those limited to qualified purchasers.

according to SEC EDGAR.

Sources
Get capital raising signals before they hit the news.
Join Waitlist